MARAGANORE JOHN
Reporting owner on Forms 3, 4 and 5, CIK 1180432.
MARAGANORE JOHN reported on 2 issuers in 3 filings, the latest a Form 4 filed 2026-10-22.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| RAPP · Rapport Therapeutics, Inc.CIK 2012593 | director | 1 | 2026-10-22 |
| CITY THERAPEUTICS, INC. CIK 2143850 | director | 2 | 2026-10-19 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| RAPP · Rapport Therapeutics, Inc.Common Stock | 2026-10-22 | P bought | +8,239 | $26.3799 | 8,239 | Form 4 |
| RAPP · Rapport Therapeutics, Inc.Common Stock | 2026-10-22 | P bought | +1,172 | $26.9173 | 9,411 | Form 4 |
| CITY THERAPEUTICS, INC. Common Stock | 2026-10-19 | C converted | +610,759 | 1,470,692 | Form 4 | |
| CITY THERAPEUTICS, INC. Series Seed convertible preferred stock, derivative | 2026-10-19 | C converted | -500,000 | $0 | 0 | Form 4 |
| CITY THERAPEUTICS, INC. Series A convertible preferred stock, derivative | 2026-10-19 | C converted | -56,095 | $0 | 0 | Form 4 |
| CITY THERAPEUTICS, INC. Common Stock, holding | 318,507 | Form 4 | ||||
| CITY THERAPEUTICS, INC. Common Stock, holding | 318,507 | Form 4 | ||||
| CITY THERAPEUTICS, INC. Stock Option (Right to Buy), derivative | 2026-10-15 | A granted | +22,649 | $0 | 22,649 | Form 4 |
| CITY THERAPEUTICS, INC. Common Stock, holding | 859,933 | Form 3 | ||||
| CITY THERAPEUTICS, INC. Common Stock, holding | 318,507 | Form 3 | ||||
| CITY THERAPEUTICS, INC. Common Stock, holding | 318,507 | Form 3 | ||||
| CITY THERAPEUTICS, INC. Series Seed convertible preferred stock, derivative, holding | Form 3 | |||||
| CITY THERAPEUTICS, INC. Series A convertible preferred stock, derivative, holding | Form 3 | |||||
| CITY THERAPEUTICS, INC. Stock Option (Right to Buy), derivative, holding | Form 3 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001193125-26-429071 | Rapport Therapeutics, Inc. | 2026-10-22 | ||
| Form 4 0001104659-26-116963 | CITY THERAPEUTICS, INC. | 2026-10-19 | ||
| Form 3 0001104659-26-116349 | CITY THERAPEUTICS, INC. | 2026-10-15 |